Q4 Recalls Snapshot: Recalled Devices At 6-Year Low; Software Issues Remain Top Recall Reason
Executive Summary
There were 152 recalls in the fourth quarter of 2017, a 9% decline from Q3, when 167 corrections & removals were initiated by device-makers. The Q4 figure also represents the lowest number of recall events in a quarter since Q4 2011. Check out our Q4 recalls infographic.
You may also be interested in...
When A Recall Hits, Embrace Your Regulator For The Common Good: Patient Safety
When a device-maker initiates a medical device recall, it's wise for the firm to work hand-in-hand with regulators to ensure that the product is removed from the market before it causes troubles for users. Chris Harvey of Stericycle ExpertSOLUTIONS offers tips in this Medtech Insight guest column for making sure that happens. He highlights five cardinal rules to ensure a smooth recall process.
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?
Thumbs Up: FDA Authorizes Weight Loss Suturing Systems From Apollo Endosurgery
People with obesity now have new tools to help them lose weight, thanks to the US agency’s de novo authorization.